China biopharma
From Fast Follower to First-in-Class Innovator: China’s 2015–2025 Drug Revolution
A decade of transformation in China’s biopharma industry: first-in-class drugs, expanded clinical pipelines, R&D talent, and billion-dollar global partnerships reshaping pharma leadership.